Money may not buy happiness, but it can help make life more satisfying, a new U.S. government survey shows. In 2021, just under 5% of U.S. adults said they were “dissatisfied” with their lives. And researchers found those feelings were more common in households making less than 200% of the federal poverty level — or…  read on >  read on >

Cardinal Health, Inc. is voluntarily recalling certain LEADER brand eyedrops because they may cause eye infections. The U.S. Food and Drug Administration informed the Dublin, Ohio, company that agency investigators found unsanitary conditions in its manufacturing facility. Tests of critical drug production areas of the facility were positive for bacteria. The drops were supplied by…  read on >  read on >

Playing professional football, especially if you are a lineman, may shorten your life, a new study suggests. The University of Minnesota researchers thought that perhaps professional football players are unlike “American men in general” in ways that determine their future health. “When we started digging into the literature on later life health outcomes for professional…  read on >  read on >

A seizure doesn’t always look like what you see in the movies, but a new survey finds most Americans don’t know what the more subtle signs of seizures are. “Anything that interrupts your brain’s circuit can cause seizures, from tumors, infections and strokes to high or low blood sugar, or glucose levels, to inherited genetic…  read on >  read on >

A new study on Clostridioides difficile infections finds that choosing an alternative antibiotic for high-risk patients with pneumonia can reduce infection risk. C. diff infections can be deadly, and they are often acquired by hospitalized patients taking broad-spectrum antibiotics.   More than 450,000 C. diff infections are reported in the United States each year, leading…  read on >  read on >

Newer oral medications for rheumatoid arthritis (RA) do work quite well in the “real world,” despite some doubts that they would, according to a new study. The study, of 622 adults with RA, found that most were doing well on medications called JAK inhibitors, a relatively new drug class for the arthritic condition. They are…  read on >  read on >